1. Home
  2. GNLN vs PTIX Comparison

GNLN vs PTIX Comparison

Compare GNLN & PTIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNLN
  • PTIX
  • Stock Information
  • Founded
  • GNLN 2005
  • PTIX 1994
  • Country
  • GNLN United States
  • PTIX United States
  • Employees
  • GNLN N/A
  • PTIX N/A
  • Industry
  • GNLN Durable Goods
  • PTIX Biotechnology: Pharmaceutical Preparations
  • Sector
  • GNLN Consumer Discretionary
  • PTIX Health Care
  • Exchange
  • GNLN Nasdaq
  • PTIX Nasdaq
  • Market Cap
  • GNLN 2.0M
  • PTIX 1.9M
  • IPO Year
  • GNLN 2019
  • PTIX 2016
  • Fundamental
  • Price
  • GNLN $0.01
  • PTIX $3.03
  • Analyst Decision
  • GNLN
  • PTIX
  • Analyst Count
  • GNLN 0
  • PTIX 0
  • Target Price
  • GNLN N/A
  • PTIX N/A
  • AVG Volume (30 Days)
  • GNLN 270.8M
  • PTIX 259.3K
  • Earning Date
  • GNLN 05-15-2025
  • PTIX 05-27-2025
  • Dividend Yield
  • GNLN N/A
  • PTIX N/A
  • EPS Growth
  • GNLN N/A
  • PTIX N/A
  • EPS
  • GNLN N/A
  • PTIX N/A
  • Revenue
  • GNLN $13,275,000.00
  • PTIX N/A
  • Revenue This Year
  • GNLN $1,541.21
  • PTIX N/A
  • Revenue Next Year
  • GNLN N/A
  • PTIX N/A
  • P/E Ratio
  • GNLN N/A
  • PTIX N/A
  • Revenue Growth
  • GNLN N/A
  • PTIX N/A
  • 52 Week Low
  • GNLN $0.01
  • PTIX $2.51
  • 52 Week High
  • GNLN $21.80
  • PTIX $26.18
  • Technical
  • Relative Strength Index (RSI)
  • GNLN 19.03
  • PTIX 45.51
  • Support Level
  • GNLN $0.01
  • PTIX $2.82
  • Resistance Level
  • GNLN $0.01
  • PTIX $3.68
  • Average True Range (ATR)
  • GNLN 0.00
  • PTIX 0.54
  • MACD
  • GNLN 0.01
  • PTIX 0.03
  • Stochastic Oscillator
  • GNLN 15.00
  • PTIX 37.16

About GNLN Greenlane Holdings Inc.

Greenlane Holdings Inc is a platform for the development and distribution of premium cannabis accessories, vape devices, and lifestyle products. It provides a wide array of consumer ancillary products and industrial ancillary products to thousands of cannabis producers, processors, brands, and retailers (Cannabis Operators). In addition, it serves specialty retailers, smoke shops, head shops, convenience stores, and consumers directly through its proprietary web stores and large online marketplaces such as Amazon. Its geographical segment includes the United States, Canada, and Europe. It derives a majority of revenue from the United States.

About PTIX Protagenic Therapeutics Inc.

Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

Share on Social Networks: